skip to content

Media

Stay up-to-date with Roche's latest news, events and announcements.

Media releases

View all releasesView ad-hoc announcements

Media events

Never miss out on past and upcoming Roche events

Media statements

Get access to the latest Roche media statements

Subscribe to Roche news

Get the latest news and updates to your inbox

patients were treated with Roche medicines in 2024

Roche Diagnostics test were delivered to customers worldwide in 2024

Core investments in research and development in 2024: CHF 13.2 billion

Annual ReportProduct Pipeline

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Dr Thomas Schinecker

CEO Roche Group

Roche has published its First Quarter Sales for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 24th April 2025.

Discover how we're revolutionalising patient care in our 2024 Annual Report. Focused on innovation, research, sustainability, and strategic partnerships, with insights into our groundbreaking approaches.

Media contacts

Do you need to get in touch with us? Reach out to our media team with your enquiries.

View media contact detailRoche Worldwide

Media library

Roche Logo

PNG

Dr. Thomas Schinecker, CEO Roche Group

JPG

Drone picture Roche Headquarters, Basel

JPG

In the spotlight

See all stories

Discover more

About RocheAbout Roche

We focus on discovering new medicines, diagnostics and digital health solutions that improve health outcomes so that we all have more time with the people we love.

Our strategyAbout Roche

We focus on discovering new medicines, diagnostics and digital products that improve health outcomes, so that we all have more time with the people we love.

InvestorsInvestors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.